Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-12-21
1984-09-11
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546121, A61K 3144, C07D47104
Patent
active
044709862
ABSTRACT:
Disclosed are e.g. 5-(tetrazolylalkyl, hydroxycarbamoylalkyl)imidazo[1,5-a]-pyridines, and methods of synthesis. Said compounds are useful as selective thromboxane synthetase inhibitors for the treatment of diseases such as cerebral ischaemia, shock, thrombosis and ischaemic heart disease.
REFERENCES:
patent: 3790586 (1974-02-01), Irikura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4256757 (1981-03-01), Hayashi et al.
patent: 4444775 (1984-04-01), Ford
P. Blatcher, et al., Tetrahedron Letters 21, 2195 (1980).
G. J. Durant, et al., J. Medicinal Chemistry 16, 1272 (1973).
W. W. Paudler, et al., J. Heterocyclic Chemistry 3, 33 (1966).
O. Fuentes, et al., J. Org. Chemistry 40, 1210 (1975).
Ciba-Geigy Corporation
Dentz Bernard
Ford John M.
Gruenfeld Norbert
LandOfFree
Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1194541